CN1781931A - Isolation of nucleic acids - Google Patents
Isolation of nucleic acids Download PDFInfo
- Publication number
- CN1781931A CN1781931A CN 200510116415 CN200510116415A CN1781931A CN 1781931 A CN1781931 A CN 1781931A CN 200510116415 CN200510116415 CN 200510116415 CN 200510116415 A CN200510116415 A CN 200510116415A CN 1781931 A CN1781931 A CN 1781931A
- Authority
- CN
- China
- Prior art keywords
- solid phase
- nucleic acid
- blood
- dna
- aforementioned arbitrary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
A method of extracting nucleic acids from blood comprises contacting blood cells, preferably after lysing with an activated solid phase at one pH to immobilise the nucleic acids and then removing the nucleic acids at a higher pH when the charge has been reversed or neutralised. The solid phase can be glass beads activated by a histidine as a binding agent. The beads can be fluidised by sucking the blood with air up through a column containing the beads to improve contact and prevent clogging.
Description
The present invention relates to a kind ofly, particularly from blood, extract the method for nucleic acid and other biological molecule from biomaterial.
Need to carry out a large amount of DNA analysis under a lot of situations, this just needs fast, safety, the separation of high yield and the method for purify DNA and other nucleic acid.
The sample that is used for that DNA identifies or analyzes can be from multiple biomaterial, such as, vegeto-animal cell, movement and tissue etc.; Also can from materials such as soil, foodstuff and water, obtain.
The existing method of extracting DNA comprises phenol/chloroform method, salting-out process, chaotropic salt and silicone resin method, affine resin method, ion exchange chromatography and paramagnetic particle method.Method is seen US patent 5057426,4923978, EP patent 0512767A1 and EP patent 0515484B, WO95/13368, WO97/10331 and WO96/18731.These patents and patent application disclose elder generation nucleic acid have been adsorbed onto on the solid support, carry out the method for separate nucleic acid then.Method in the past all is with some inflammable, flammable or deleterious separated from solvent nucleic acid.
Blood is a kind ofly to be used for the abundantest sample source of DNA analysis, because blood sample can be by numerous former thereby conventional acquisitions.Yet, when using existing DNA extraction method, because the thickness of blood and be rich in the character of proteolytic enzyme, handle the unusual difficulty of large volume blood that contains relatively small amount DNA, therefore be difficult to automatization and finish.Up to now, nucleic acid extraction can only rely on use hazardous agents and slowly operation steps carry out automatization partly.
I have invented a kind of being used for and have extracted improving one's methods of nucleic acid and other biomolecules from blood and other biomaterial now.
The invention provides a kind of method of from biomaterial, extracting biomolecules, this method comprises: at first contact biomaterial with solid phase that can binding biomolecules in a pH value, extract by the biomolecules that will be attached to solid phase with a kind of eluent wash-out in the 2nd pH value then.
Present method is specially adapted to blood-material, also can be widely used in other material, for example separating of plasmid and carrier, and the extraction of DNA of plants.
Preferably with the lysis in the blood to discharge nucleic acid molecule.Can use known cracking agent and method, for example contact with non-ionic detergent, hypotonic salts solution, proteolytic enzyme, chaotropic agent, solvent, change change pH values or heating with ionic.The method of the lysing cell that isolating nucleic acid adopted is seen WO 96/00228.
When biomaterial was blood, sample is water or other solvent cut arbitrarily, so that operation and further processing.
Sample can dilute nearly ten times of uses, and higher generally speaking extension rate may be better.Characteristics of the present invention are to use the blood of dilution for many times.
The solid phase that contacts with blood can perhaps be made through the material of certain agent treated by the surface by nucleic acid there being the material of natural avidity make, and this reagent makes nucleic acid can be combined on the solid phase or increases the avidity of solid phase to nucleic acid.Suitable material comprises controlled pore glass, polysaccharide (agarose or Mierocrystalline cellulose), other type silica/glass, stupalith, porous plastic materials, for example sponge plastics plug (it is in an independent molding part, or the insertion body in standard pipe), polystyrene bead and paramagnetic beads etc.The size of material and porosity are not strict with, and according to different purposes different selections can be arranged.
The appropriate method of handling solid phase surface or derivatize processing solid phase comprises with a kind of and can import electric charge at solid phase surface, positive charge for example, perhaps add hydrophilic or hydrophobic surface, for example the mass treatment solid phase surface of hydroxyl, nitro, autoreaction group, dyestuff and other aromatics to solid phase.
In a preferred embodiment of the invention, the impurity that solid phase can make DNA have precedence in the blood sample when a pH value is attached on it, and when different pH values because the contact of eluent, the nucleic acid that has been attached to solid phase will be released.Native system can use with the solid phase of having mixed Histidine or poly Histidine, described solid phase when lower pH value, for example the pH value less than 6 o'clock with bind nucleic acid, and when the pH value raises, for example greater than 8 o'clock bonded nucleic acid be released.Perhaps, nucleic acid is attached to the amination surface when basic neutral pH value, and is released when very high pH value.
In another embodiment of the present invention, can in plastic ware, mix wedding agent, for example in a hole of flat board, make wedding agent be added into its surface, so blood sample is contacted with the surface, nucleic acid is attached on the surface.After blood sample is removed, handle vessel surface, discharge combined nucleic acid with eluent.When surface in contact is in the porous flat plate during bore portion, total system is applicable to rapid large-scale sampling and extractive technique.
The wedding agent that is suitable for comprises the electric charge switching mode ion exchange resin that uses positively charged solid phase, this solid phase can be reversed into electronegative or become neutrality to being higher than its pKa by changing change pH values, for example, Nucleotide, polyamines, imidazole group and other have the similar reagents of suitable pKa value.
And nucleic acid also can be used the multiple embedded type compound that is incorporated into solid phase, for example dactinomycin, ethidium bromide etc., the combination by insertion reaction.
In another embodiment of the present invention, can modify frosting and make it contain functional group.These plastics can be any plastics that can be used for holding sample, for example polypropylene.Functional group can positively charged or negative charge, thus in correct damping fluid bind nucleic acid.
Perhaps, functional group also can be can with the chemical group of other aglucons or polymkeric substance covalent coupling.
When in mould of plastics, when for example using plastics in the Ping Ban hole or in the PCR pipe, the character of frosting can be by in mold compound (moulding compound), for example injecting that pattern inhibition and generation compound comprises or add suitable chemical modification to be used for the present invention.
When using frosting in the PCR pipe or in the deep hole flat board, these pipes or hole can be used for separating and fixing a spot of DNA or RNA, obtain can be used for carrying out the purifying masterplate that next step PCR reacts or carries out other genetic analysis and operation.
When plastics are polypropylene material, thin-walled PCR pipe for example, polypropylene surface can be carried out oxidation and potassium permanganate and sulfuric acid are for example used in modification with oxygenant, to cause carboxylation surface (COOH group).Such PCR pipe can improve from solution or the product that slightly get sample in, for example in the blood, carry out the separation of DNA.By adjusting pH value, specific inductivity, solubleness or ionic strength, DNA or RNA can be fixed on the tube wall, and eccysis impurity, be directly used in PCR or other analytical technology.
Carboxylic group can also by with anionic group, for example imidazoles, poly Histidine or other strong or weak ion-exchanger covalent coupling and be modified are so that rely on the interaction of electric charge to come bind nucleic acid.This pipe can improve from solution or the product that slightly get sample in, for example in the blood, carry out the separation of DNA.Can DNA or RNA be fixed on the tube wall by adjusting pH value, specific inductivity or ionic strength equally, and eccysis impurity, be directly used in PCR or other analytical technology.
Nucleic acid can be in low salts solution wash-out, to be ready for use on PCR or other analysis.
By in the mixed/stirred device with solid phase mixing, allow blood sample through solid phase, and blood sample contacted with solid phase.Perhaps solid phase can be paramagnetic and operate in magnetic field.Although the present invention is specially adapted to isolating nucleic acid from blood, also can be used for various biomolecules, particularly those need remove the biomolecules of cell wall fragments or insoluble particle.
In a preferred embodiment of the invention, solid phase is particulate state in post, and blood relies on the pressure reduction that is added on the post and passes through post, and blood sample is crossed post by air pressure stream, and granular solid material is fluidized, and mixes and contact rate with reinforcement, and reduces and stop up.
Method of the present invention is suitable for carrying out in the porous mode, wherein carries out a series of extraction basically simultaneously in different samples, and this will be convenient to the automatization of leaching process, to finish quick, a large amount of extractions and to carry out the combinatorial chemistry reaction.In the series of standards hole, carry out big output and extract, for example in 8 * 12 holes, handle a large amount of samples at one time automatically.
The present invention describes in an embodiment.
Embodiment 1
From whole blood, extract nucleic acid
With glutaldehyde with poly Histidine covalent coupling to 100 (on the m granulated glass sphere, be about to 1 donaxine bead and 0.01% (v/v) glutaldehyde and containing 20mg poly Histidine, thereby mix preparation electric charge switching mode ion-exchanger in the 0.1M sodium hydrogen carbonate solution of pH value 8.After being incubated overnight, thoroughly washing bead and contain 0.1% (v/v) Tween 20, among the 10mM MES of pH5 to remove non-covalent bonded material, to be stored in.
(the about 300mg of m derivatize bead adds 1ml and seals in the plastic column at two ends with 100.
With blood sample with volume contain 1%Tween 20, (the 10mM MES (pH5) of 200 (g/ml) and 1mMEDTA mixes proteolytic enzyme.After the digestion fully, the blood suction is contained in the post of bead, DNA is fixed immediately, and impurity albumen flows out by pillar and goes out of use.
The bead that contains the DNA that is fixed washs with the damping fluid that contains 10mM MES pH5, and this MES contains 1%Tween20 and 1mM EDTA.The repeated washing process, colourless up to washings.
After the washing, the dry air bead, with a small amount of 10mM Tris HCl, the pH8.5 eluted dna is collected in the sterile tube then in order to further analyzing experiment.Like this, promptly from blood, isolated DNA.
At different biomolecules, damping fluid etc. can be cooked appropriate change.
Embodiment 2
1 gram carboxylation paramagnetic beads with 50mM imidazole buffer (pH6) washing after, mix with 100mg poly Histidine in being dissolved in 50ml 50mM imidazole buffer (pH6).Adding the straight final concentration of chemical coupling agent (EDC) is 5mg/ml, and mixing is spent the night.Paramagnetic beads is stored in 10mM MES, 0.1%Tween 20pH5 with the solution washing that contains 0.5M sodium-chlor, 1%Tween 20,100mM Tris HCl pH8.
In order from blood, to extract DNA, with the 1mg paramagnetic beads be diluted in 10%Tween 20,25mMMES, the blood among the 1mM EDTA pH5 mixes.Isolate paramagnetic beads with magnet, be resuspended in 1mM MES, washing among the 0.1%Tween 20.For eluted dna, paramagnetic beads is resuspended in 10mM Tris HClpH8.5, with magnet it is separated, and DNA resides in the solution.
Claims (35)
1. method of from biomaterial, extracting biomolecules, this method comprise with biomaterial a pH value with can contact in conjunction with the solid phase of described biomolecules, extract by the biomolecules that wash-out will be attached on the solid phase with elutriant in the 2nd pH value then.
2. according to the process of claim 1 wherein that described biomolecules comprises nucleic acid.
3. according to the method for claim 1 or 2, wherein said biomaterial is a blood.
4. according to claim 1,2 or 3 method, wherein said biomolecules contacts with solid phase less than 6 o'clock at pH, and DNA is incorporated on the solid phase, and DNA is discharged from solid phase greater than 8 o'clock at pH.
5. according to claim 1,2 or 3 method, wherein said biomolecules contacts with solid phase when basic neutral pH, and DNA is incorporated on the solid phase, and DNA is discharged from solid phase greater than 10 o'clock at pH.
6. according to method any in the claim 3 to 5, wherein the cell in the blood discharges nucleic acid by cracking.
7. according to the method for claim 6, wherein cell is by contacting with ion or non-ionic detergent, hypotonic salts solution, proteolytic enzyme or chaotropic agent, and is perhaps cleaved by changing change pH values or heating.
8. according to method any in the claim 3 to 7, wherein the dilution of blood water or other thinner is so that operate and pour into.
9. method according to Claim 8, wherein the hemodilution degree is up to 10 times.
10. according to the method for aforementioned arbitrary claim, wherein the solid phase that contacts with biomaterial is by nucleic acid there being the material of natural avidity make.
11. according to the method for aforementioned arbitrary claim, wherein the solid phase that contacts with biomaterial is through making nucleic acid in conjunction with on it or strengthen its material that agent treated of the avidity of nucleic acid is crossed and make by the surface.
12. according to the method for claim 11, wherein the surface of solid material is with positively charged or possess hydrophilic property of solid phase surface or hydrophobic material are handled.
13. according to the method for claim 11, use therein binding reagents is the electric charge switching mode ion exchange resin that adopts positively charged solid phase, can by change change pH values to its pKa value or under reverse or neutralize electrical.
14. according to the method for claim 13, wherein binding reagents can be Nucleotide, polyamines, or contains the compound of imidazoles part.
15., wherein utilize the embedded type compound that is incorporated in the solid phase, bind nucleic acid by embedding according to the method for claim 11.
16. according to the method for claim 15, wherein dyestuff is dactinomycin or ethidium bromide.
17. according to the method for claim 11, wherein handle with Histidine or poly Histidine on the solid phase material surface.
18. according to the method for aforementioned arbitrary claim, wherein solid phase is controlled pore glass, polysaccharide, stupalith or porous plastic materials.
19. according to the method for aforementioned arbitrary claim, wherein solid phase comprises polystyrene bead or paramagnetic material pearl.
20. according to the method for aforementioned arbitrary claim, wherein solid phase comprises the frosting that has functional group through modification.
21. according to the method for claim 20, wherein plastics are polypropylene.
22. according to the method for claim 21, wherein polypropylene surface is modified by the oxygenant oxidation, forms the carboxylation surface.
23. according to the method for claim 22, wherein carboxyl is by covalent coupling anionic group, for example imidazoles, poly Histidine or any strong or weak ion-exchanger and by further modification make nucleic acid by coulombic interaction and combination.
24. according to method any in the claim 11 to 23, the positively charged or negative charge of wherein said functional group is with bind nucleic acid.
25. according to method any in the claim 11 to 23, wherein said functional group be can with the chemical group of other aglucon or polymkeric substance covalent coupling.
26. according to method any in the claim 20 to 25, wherein solid material is the sponge plastics plug, it is an independent molding part, or the insertion body in the container.
27. according to method any in the claim 20 to 25, wherein plastics are in the mould of plastics.
28. according to the method for claim 27, wherein solid material is polymerase chain reaction (PCR) pipe.
29. according to the method for claim 27, wherein solid material is the deep hole flat board.
30. according to method any in the claim 26 to 29, wherein pipe or hole are used for separating and fixing a small amount of DNA or RNA, obtain the pure masterplate that can be used for next step PCR reaction or carry out other genetic analysis and operation.
31. method according to aforementioned arbitrary claim, wherein solid phase comprises the particulate solid material, mixes with solid phase material in the mixed/stirred device by making blood sample, makes blood sample pass through solid phase, and blood sample is contacted with solid phase, or on magnetisable upholder, operate solid phase.
32. according to the method for aforementioned arbitrary claim, wherein container is the hole in the porous flat plate, can carry out a series of DNA extraction to different samples simultaneously basically.
33. according to the method for aforementioned arbitrary claim, wherein solid phase is particulate state in post, blood passes through post by means of being added in the pressure reduction on the post.
34. according to the method for claim 33, wherein blood sample is crossed post by air pressure stream, and granular solid material is fluidized.
35. according to the method for aforementioned arbitrary claim, wherein said biomolecules is by taking out with low salt buffer or water elution.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9725839.6A GB9725839D0 (en) | 1997-12-06 | 1997-12-06 | Isolation of nucleic acids |
| GB9725839.6 | 1997-12-06 | ||
| GB9815541.9 | 1998-07-17 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB988118939A Division CN1230440C (en) | 1997-12-06 | 1998-12-04 | Isolation of nucleic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1781931A true CN1781931A (en) | 2006-06-07 |
Family
ID=10823220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510116415 Pending CN1781931A (en) | 1997-12-06 | 1998-12-04 | Isolation of nucleic acids |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN1781931A (en) |
| GB (1) | GB9725839D0 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101289661B (en) * | 2007-04-20 | 2013-08-21 | 霍夫曼-拉罗奇有限公司 | Isolation and purification of nucleic acid molecules with solid phase |
| CN103439174A (en) * | 2013-09-18 | 2013-12-11 | 武汉大学 | Method for extracting nucleoside in sample by taking titanium dioxide as solid phase |
| CN104254597A (en) * | 2012-02-29 | 2014-12-31 | Bd公司 | Formulations and process for isolating viable microorganism from positive blood cultures |
| US9422543B2 (en) | 2008-08-08 | 2016-08-23 | Cambridge Enterprise Limited | Isolation of nucleic acid |
| CN107955810A (en) * | 2017-12-25 | 2018-04-24 | 宁波卡尔新材料科技有限公司 | A kind of new animal's liver nucleic acid extraction kit and extracting method |
-
1997
- 1997-12-06 GB GBGB9725839.6A patent/GB9725839D0/en not_active Ceased
-
1998
- 1998-12-04 CN CN 200510116415 patent/CN1781931A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101289661B (en) * | 2007-04-20 | 2013-08-21 | 霍夫曼-拉罗奇有限公司 | Isolation and purification of nucleic acid molecules with solid phase |
| US9422543B2 (en) | 2008-08-08 | 2016-08-23 | Cambridge Enterprise Limited | Isolation of nucleic acid |
| CN104254597A (en) * | 2012-02-29 | 2014-12-31 | Bd公司 | Formulations and process for isolating viable microorganism from positive blood cultures |
| US10519482B2 (en) | 2012-02-29 | 2019-12-31 | Becton, Dickinson And Company | Formulations and process for isolating viable microorganisms from positive blood cultures |
| US11225681B2 (en) | 2012-02-29 | 2022-01-18 | Becton, Dickinson And Company | Formulations and process for isolating viable microorganisms from positive blood cultures |
| CN103439174A (en) * | 2013-09-18 | 2013-12-11 | 武汉大学 | Method for extracting nucleoside in sample by taking titanium dioxide as solid phase |
| CN107955810A (en) * | 2017-12-25 | 2018-04-24 | 宁波卡尔新材料科技有限公司 | A kind of new animal's liver nucleic acid extraction kit and extracting method |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9725839D0 (en) | 1998-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1230440C (en) | Isolation of nucleic acids | |
| EP1674571B1 (en) | Use of paramagnetic material in the purification and manipulation of nucleic acids | |
| US6914137B2 (en) | Isolation of nucleic acids | |
| US6355792B1 (en) | Method for isolating and purifying nucleic acids | |
| US20060024701A1 (en) | Methods and reagents for the isolation of nucleic acids | |
| US20090069554A1 (en) | Method for isolating nucleic acids comprising the use of ethylene glycol multimers | |
| US11702648B2 (en) | Process for concentrating cells from a sample and then isolating nucleic acids from said cells | |
| JP2004501054A5 (en) | ||
| KR20140120916A (en) | Biomolecule isolation | |
| CA2375449A1 (en) | Sample processing device | |
| EP1920054A1 (en) | Method for separating and purifying rna | |
| CN1781931A (en) | Isolation of nucleic acids | |
| EP1454983A1 (en) | Process for recovery of nucleic acids | |
| MXPA00005474A (en) | Isolation of nucleic acids | |
| US20240158777A1 (en) | Magnetic bead suspension reagent, method for purifying nucleic acid and method for sorting nucleic acid | |
| CA2552010A1 (en) | Method for enriching and stabilising components which contain dna and which are made of biological materials | |
| JP2005176678A (en) | Method for separating and purifying nucleic acid | |
| JP2005168450A (en) | Method for separation and purification of nucleic acid | |
| JP2005137297A (en) | Method for separating and purifying nucleic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| PB01 | Publication | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20060407 Address after: American California Applicant after: Invitrogen Corp. Address before: Kent England Applicant before: DNA Res Innovations Ltd. |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |